Delivery Order SPE2DB24D2205-SPE2DB25FDWRE

Award Date 1/8/25
Potential Completion Date 1/30/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,701.40 contract is for the delivery of COMIRNATY 2024-25 (12Y UP) 0.3ML syringes, which are likely COVID-19 vaccines. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COMIRNATY 2024-25 (12Y UP) syringes (0.3ML). The contract has a ceiling value of $1,480.58 and a period of performance through February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $2,220.84 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes at 0.3 ML, with a completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the COMIRNATY 2024-25(12Y UP) SYRG 0.3ML pharmaceutical product. The contract has a ceiling value of $1,480.58 and runs through January 17, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and there are no major subcontractors listed. This contract is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,220.84, is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, a vaccine product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,701.40 delivery order is for the procurement of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML syringes. The contract has a firm fixed price pricing type and an ultimate completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,701.40 Firm Fixed Price delivery order contract is for the supply of COMIRNATY 2024-25 (12Y UP) syringes with a 0.3 mL volume. The contract has an ultimate completion date of December 17, 2024 and was awarded on November 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, a pharmaceutical product, with a ceiling value of $18,007.60. The contract has a firm-fixed price pricing type and an ultimate completion date of September 18, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, with ID SPE2DB20D1051|SPE2DB25F1531, is a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML, with a ceiling value of $1,431.12 and a completion date of November 26, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 firm fixed-price contract is for the delivery of COMIRNATY 2024-25(12Y UP) SYRG 0.3ML, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDWRE
    Delivery Order

This is a $5,922.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of COMIRNATY 2024-25 (12Y UP) SYRG 0.3ML. The contract has an ultimate completion date of January 30, 2025. This award is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is not designated as a set-aside.

Generated 4/9/25, 9:49 AM